|
Topic area
|
Number of trials
|
Phase
|
Number of participants
|
|---|
| | |
I
|
II
|
III
|
IV
|
N/A
| |
|---|
|
Cancer
|
7
| |
1
|
4
|
1
|
1
|
27314*
|
|
Cardiac/circulation
|
8
| |
1
|
4
|
3
| |
56335
|
|
Diabetes
|
7
| | | |
3
|
4
|
16350*
|
|
Infectious disease
|
25
|
19
|
3
| |
1
|
1
|
1737*
|
|
Neo/perinatal
|
4
| | |
1
|
2
|
1
|
7220
|
|
Nervous system
|
2
| | |
2
| | |
312
|
|
Obstetrics/gynaecology
|
2
| | |
1
|
1
| |
240
|
|
Paediatrics
|
17
| |
8
|
2
|
6
|
1
|
5510
|
|
Public health/primary care
|
1
| | | |
1
| |
180
|
|
Psychiatry
|
8
|
1
|
2
| |
4
|
1
|
1853
|
|
Renal
|
2
| | |
1
|
1
| |
848
|
|
Respiratory medicine
|
4
| |
1
|
1
|
2
| |
686
|
|
Tropical medicines
|
53
|
9
|
15
|
8
|
7
|
14
|
36303*
|
|
Total
|
140
|
29
|
31
|
24
|
32
|
23
|
154888
|
- *incomplete data.
- Source: Clinical Trials and Research Governance Team, University of Oxford.
